Evidence map›Paper›PMID 38229033›Full record

ArticleCellular & molecular biology letters2024

SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells.

Rocío Seoane, Tomás Lama-Díaz, Antonia María Romero, Ahmed El Motiam, Arantxa Martínez-Férriz, Santiago Vidal, Yanis H Bouzaher, María Blanquer, Rocío M Tolosa, Juan Castillo Mewa and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. eIF5A coordinates the transcription and translation of its target genes.Cellular and molecular life sciences : CMLS · 2026
    Article
  3. Review
  4. The role of polyamine metabolism in cellular function and physiology.American journal of physiology. Cell physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 5 countries.

Rocío SeoaneCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-7536-8702
Tomás Lama-DíazCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-8568-2375
Antonia María RomeroDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universitat de València, Burjassot, 46100, Valencia, Spain.ORCID http://orcid.org/0000-0002-2727-279X
Ahmed El MotiamCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0003-2855-1368
Arantxa Martínez-FérrizCentro de Investigación Príncipe Felipe, 46012, Valencia, Spain.ORCID http://orcid.org/0000-0001-7193-2575
Santiago VidalCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-0105-4583
Yanis H BouzaherCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-0956-5417
María BlanquerCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-0750-8750
Rocío M TolosaCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0009-0005-4520-4802
Juan Castillo MewaResearch Department in Genomics and Proteomics, Instituto Conmemorativo Gorgas de Estudios de la Salud, 0816-02593, Panamá, Republic of Panama.ORCID http://orcid.org/0000-0001-7764-6561
Manuel S RodríguezLaboratoire de Chimie de Coordination LCC-UPR 8241-CNRS, 31400, Toulouse, France.ORCID http://orcid.org/0000-0001-5445-4495
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-6551-1827
Dimitris XirodimasMontpellier Cell Biology Research Center (CRBM), CNRS-UMR 5237 Université de Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0001-9275-1140
James D SutherlandCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.ORCID http://orcid.org/0000-0003-3229-793X
Rosa BarrioCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.ORCID http://orcid.org/0000-0002-9663-0669
Paula AlepuzDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universitat de València, Burjassot, 46100, Valencia, Spain.ORCID http://orcid.org/0000-0003-1472-2373
Miguel G BlancoCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain.ORCID http://orcid.org/0000-0002-2883-7326
Rosa FarràsCentro de Investigación Príncipe Felipe, 46012, Valencia, Spain.ORCID http://orcid.org/0000-0003-4931-1494
Carmen RivasCentro de Investigación en Medicina Molecular (CIMUS), IDIS, Universidade de Santiago de Compostela, Avda Barcelona, 15706, Santiago de Compostela, Spain. mcarmen.rivas@usc.es.ORCID http://orcid.org/0000-0002-0518-7199
Center for Research in Molecular Medicine and Chronic Diseases · ESCentre National de la Recherche Scientifique · FRCentro de Investigacion Principe Felipe · ESCIC bioGUNE · ESUniversidade de Santiago de Compostela · ESUniversitat de València · ESCentro Nacional de Biotecnología · ESIcahn School of Medicine at Mount Sinai · USInstituto Conmemorativo Gorgas de Estudios de la Salud · PAMount Sinai Hospital · CA

Funding

Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia ED431G 2019/02Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia ED431G 2023/10cost action proteocure CA20113Instituto de Salud Carlos III PI20-00194Ministerio de Ciencia, Innovación y Universidades PID2020-114178GB-I00Ministerio de Ciencia, Innovación y Universidades PID2020-115472GB-I00Ministerio de Ciencia, Innovación y Universidades PID2020-120066RB-I00Ministerio de Ciencia, Innovación y Universidades PID2021-126510NB-I00Severo Ochoa Excellence Program CEX2021-001136-S
6 · The paper itself

Abstract

backgroundThe eukaryotic translation initiation protein eIF5A is a highly conserved and essential factor that plays a critical role in different physiological and pathological processes including stress response and cancer. Different proteomic studies suggest that eIF5A may be a small ubiquitin-like modifier (SUMO) substrate, but whether eIF5A is indeed SUMOylated and how relevant is this modification for eIF5A activities are still unknown.

methodsSUMOylation was evaluated using in vitro SUMOylation assays, Histidine-tagged proteins purification from His6-SUMO2 transfected cells, and isolation of endogenously SUMOylated proteins using SUMO-binding entities (SUBES). Mutants were engineered by site-directed mutagenesis. Protein stability was measured by a cycloheximide chase assay. Protein localization was determined using immunofluorescence and cellular fractionation assays. The ability of eIF5A1 constructs to complement the growth of Saccharomyces cerevisiae strains harboring thermosensitive mutants of a yeast EIF5A homolog gene (HYP2) was analyzed. The polysome profile and the formation of stress granules in cells expressing Pab1-GFP (a stress granule marker) by immunofluorescence were determined in yeast cells subjected to heat shock. Cell growth and migration of pancreatic ductal adenocarcinoma PANC-1 cells overexpressing different eIF5A1 constructs were evaluated using crystal violet staining and transwell inserts, respectively. Statistical analysis was performed with GraphPad Software, using unpaired Student's t-test, or one-way or two-way analysis of variance (ANOVA).

resultsWe found that eIF5A is modified by SUMO2 in vitro, in transfected cells and under endogenous conditions, revealing its physiological relevance. We identified several SUMO sites in eIF5A and found that SUMOylation modulates both the stability and the localization of eIF5A in mammalian cells. Interestingly, the SUMOylation of eIF5A responds to specific stresses, indicating that it is a regulated process. SUMOylation of eIF5A is conserved in yeast, the eIF5A SUMOylation mutants are unable to completely suppress the defects of HYP2 mutants, and SUMOylation of eIF5A is important for both stress granules formation and disassembly of polysomes induced by heat-shock. Moreover, mutation of the SUMOylation sites in eIF5A abolishes its promigratory and proproliferative activities in PANC-1 cells.

conclusionsSUMO2 conjugation to eIF5A is a stress-induced response implicated in the adaptation of yeast cells to heat-shock stress and required to promote the growth and migration of pancreatic ductal adenocarcinoma cells.

Indexed as

AdenocarcinomaSaccharomyces cerevisiaeAnimalsEukaryotic Initiation Factor-5HumansMammalsProteomicsSaccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsSumoylationUbiquitineIF5A protein, S cerevisiaeEukaryotic Initiation Factor-5Saccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsUbiquitineIF5APancreatic ductal adenocarcinomaStress granulesStress responseSUMO2

Identifiers

PMID38229033
PMCPMC10790418
OpenAlexW4390904431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.